RSS   Newsletter   Contact   Advertise with us

Genevant Sciences appoints chief scientific officer and COO

Share on Twitter Share on LinkedIn
Staff Writer | Basel, Switzerland |
Genevant SciencesGenevant Sciences, a biopharmaceutical company, announced the appointment of Margrit Schwarz as chief scientific officer and head of R&D, and Pete Zorn as chief operating officer.
Margrit Schwarz joins Genevant from Roche Pharmaceuticals, Basel, Switzerland, where she was Vice President and Global Head, External Innovation.

Prior to the engagement at Roche, Dr. Schwarz held appointments as VP and Therapeutic Area Head at Boehringer Ingelheim, Ridgefield, CT, and Director Research at Amgen, South San Francisco, CA.

Prior to joining Amgen, Dr. Schwarz held scientific leadership roles in discovery research at F. Hoffmann-La Roche, Basel, and at Tularik, South San Francisco.

Dr. Schwarz holds a PhD in Biochemistry from the University of Cologne, Germany and an MBA from Columbia University, New York, and is the author of numerous publications and several issued patents.

Pete Zorn served most recently as Chief Corporate Officer and General Counsel at Albireo Pharma where he led the corporate development, legal, corporate communications and human resource functions.

Previously, Mr. Zorn was General Counsel and Vice President, Communications at Santaris Pharma and Senior Vice President and General Counsel at Targacept.

Mr. Zorn began his career at a large law firm in North Carolina and received his undergraduate degree with honors from Harvard and his law degree with honors from the University of North Carolina at Chapel Hill.


 LATEST MOVES FROM Switzerland 


POST Online Media Contact